Floatz logo

IBUPROFEN

Knee Arthropathy

Medipol UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Knee Arthropathy cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
Poznan University of Medical Sciences
Phase 4BBB
NEPENTHE
Poznan University of Medical Sciences
Phase 4BB
DEXKETOPROFEN
Poznan University of Medical Sciences
Phase 4BB
METAMIZOLE
Poznan University of Medical Sciences
Phase 4BB
FENTANYL
Medipol University
N/AD
(±)-TRAMADOL
Medipol University
N/AD

Same molecule, other indications

IBUPROFEN is also rated in:

chronic pain syndromeDormant
BBB
Indicative ·
72 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
72 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →